157 related articles for article (PubMed ID: 36657849)
21. Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson's disease.
Li QM; Xu T; Zha XQ; Feng XW; Zhang FY; Luo JP
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117196. PubMed ID: 37717841
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
23. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors.
Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H
J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162
[TBL] [Abstract][Full Text] [Related]
24. Lutein protects dopaminergic neurons against MPTP-induced apoptotic death and motor dysfunction by ameliorating mitochondrial disruption and oxidative stress.
Nataraj J; Manivasagam T; Thenmozhi AJ; Essa MM
Nutr Neurosci; 2016 Jul; 19(6):237-46. PubMed ID: 25730317
[TBL] [Abstract][Full Text] [Related]
25. Pyruvate Prevents Dopaminergic Neurodegeneration and Motor Deficits in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease.
Kim YM; Choi SY; Hwang O; Lee JY
Mol Neurobiol; 2022 Nov; 59(11):6956-6970. PubMed ID: 36057709
[TBL] [Abstract][Full Text] [Related]
26. Fucoidan Protects Dopaminergic Neurons by Enhancing the Mitochondrial Function in a Rotenone-induced Rat Model of Parkinson's Disease.
Zhang L; Hao J; Zheng Y; Su R; Liao Y; Gong X; Liu L; Wang X
Aging Dis; 2018 Aug; 9(4):590-604. PubMed ID: 30090649
[TBL] [Abstract][Full Text] [Related]
27. Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells.
Lim JD; Lee SR; Kim T; Jang SA; Kang SC; Koo HJ; Sohn E; Bak JP; Namkoong S; Kim HK; Song IS; Kim N; Sohn EH; Han J
Mar Drugs; 2015 Feb; 13(2):1051-67. PubMed ID: 25690093
[TBL] [Abstract][Full Text] [Related]
28. Triple herbal extract DA-9805 exerts a neuroprotective effect via amelioration of mitochondrial damage in experimental models of Parkinson's disease.
Jeong JS; Piao Y; Kang S; Son M; Kang YC; Du XF; Ryu J; Cho YW; Jiang HH; Oh MS; Hong SP; Oh YJ; Pak YK
Sci Rep; 2018 Oct; 8(1):15953. PubMed ID: 30374025
[TBL] [Abstract][Full Text] [Related]
29. Cannabidiol Alleviates the Damage to Dopaminergic Neurons in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease Mice Via Regulating Neuronal Apoptosis and Neuroinflammation.
Wang L; Wu X; Yang G; Hu N; Zhao Z; Zhao L; Li S
Neuroscience; 2022 Aug; 498():64-72. PubMed ID: 35792194
[TBL] [Abstract][Full Text] [Related]
30. Fucoidan from Fucus vesiculosus suppresses hepatitis B virus replication by enhancing extracellular signal-regulated Kinase activation.
Li H; Li J; Tang Y; Lin L; Xie Z; Zhou J; Zhang L; Zhang X; Zhao X; Chen Z; Zuo D
Virol J; 2017 Sep; 14(1):178. PubMed ID: 28915824
[TBL] [Abstract][Full Text] [Related]
31. Enzyme-Assisted Fucoidan Extraction from Brown Macroalgae
Nguyen TT; Mikkelsen MD; Tran VHN; Trang VTD; Rhein-Knudsen N; Holck J; Rasin AB; Cao HTT; Van TTT; Meyer AS
Mar Drugs; 2020 Jun; 18(6):. PubMed ID: 32498331
[TBL] [Abstract][Full Text] [Related]
32. 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.
Shi L; Jia L; Wang Y; Xiu M; Xie J
Neurochem Res; 2023 Jun; 48(6):1707-1715. PubMed ID: 36602724
[TBL] [Abstract][Full Text] [Related]
33. Assessment of zymosan-induced leukocyte influx in a rat model using sulfated polysaccharides.
Cardoso ML; Xavier CA; Bezerra MB; Paiva AO; Carvalho MF; Benevides NM; Rocha FA; Leite EL
Planta Med; 2010 Feb; 76(2):113-9. PubMed ID: 19653146
[TBL] [Abstract][Full Text] [Related]
34. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
[TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of hyperoside in MPP
Xu XJ; Pan T; Fan HJ; Wang X; Yu JZ; Zhang HF; Xiao BG; Li ZY; Zhang B; Ma CG; Chai Z
Metab Brain Dis; 2023 Mar; 38(3):1035-1050. PubMed ID: 36576692
[TBL] [Abstract][Full Text] [Related]
36. Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
Lee Y; Heo G; Lee KM; Kim AH; Chung KW; Im E; Chung HY; Lee J
Brain Res; 2017 May; 1663():184-193. PubMed ID: 28322751
[TBL] [Abstract][Full Text] [Related]
37. The potent activity of sulfated polysaccharide, ascophyllan, isolated from Ascophyllum nodosum to induce nitric oxide and cytokine production from mouse macrophage RAW264.7 cells: Comparison between ascophyllan and fucoidan.
Jiang Z; Okimura T; Yamaguchi K; Oda T
Nitric Oxide; 2011 Nov; 25(4):407-15. PubMed ID: 22024029
[TBL] [Abstract][Full Text] [Related]
38. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
39. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
40. Potential Beneficial Actions of Fucoidan in Brain and Liver Injury, Disease, and Intoxication-Potential Implication of Sirtuins.
Dimitrova-Shumkovska J; Krstanoski L; Veenman L
Mar Drugs; 2020 May; 18(5):. PubMed ID: 32380741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
